Trip.com Antitrust Investigation Weighs on Shares
Trip.com antitrust investigation announced Jan. 14 raises regulatory risk and could prompt volatility and selling pressure on shares.
KEY TAKEAWAYS
- SAMR opened an investigation under China's Anti-Monopoly Law into suspected monopoly practices in online travel services.
- Trip.com said it would actively cooperate with regulators and that business operations would not be disrupted.
- The disclosure foregrounds regulatory risk and governance concerns for investors in China online travel platforms.
HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX
Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.
Trip.com Group Limited (NASDAQ: TCOM) said on Jan. 14 that it received a notice from China’s State Administration for Market Regulation (SAMR) opening an antitrust investigation. The company said it will cooperate with the regulator and that business operations will continue without disruption.
SAMR Opens Investigation Under Anti-Monopoly Law
China’s top market regulator, SAMR, has launched a probe under the Anti-Monopoly Law of the People’s Republic of China into suspected monopoly practices in online travel services. The investigation targets the sector where Trip.com operates, signaling formal regulatory scrutiny.
SAMR has a history of high-profile enforcement, including a 2021 fine of RMB18.2 billion on a major platform for similar conduct, highlighting the potential risks for companies under investigation.
Trip.com Pledges Cooperation as Operations Continue
Trip.com said in a PRNewswire release from Singapore that it will actively cooperate with the investigation and fully implement regulatory requirements. The company added that its business operations are proceeding normally and will not be disrupted.
As a global, one-stop travel services provider offering accommodation reservations, transportation ticketing, packaged tours, and corporate travel management, Trip.com is directly affected by the regulator’s focus on online travel services.
The disclosure places regulatory risk and governance concerns at the forefront for investors as the SAMR inquiry advances, affecting how platforms in China are evaluated under the Anti-Monopoly Law.
